Project Grant HT9425261E260
Award Date 6/15/26
Completion Date 6/14/30
Dollars Obligated $603K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
South Miami, FL 33146, USA
Similar Awards
- Federal Project Grant Award Summary The University of Miami's Office of Research Administration received a $1,092,670 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on June 15, 2026, with a completion date of June 14, 2030. The award funds research titled "Bringing Alzheimer's Detection to the Front Lines: Evaluating Novel Cognitive and Plasma Biomarkers in Primary Care," conducted at the...
- Federal Grant Award Summary The University of Miami's Office of Research Administration - School of Medicine received a $999,999 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded on June 1, 2026, with a completion date of May 31, 2029. This award supports the development of a Schwann cell-derived extracellular vesicle platform designed to advance biomarker discovery for amyotrophic lateral sclerosis (ALS) in...
- Federal Grant Award Summary The University of Miami, through its Office of Research Administration at the School of Medicine, received a $490,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period July 1, 2026 to June 30, 2028. The award supports research focused on elucidating metabolic-epigenetic rewiring in chordoma, a rare malignant tumor. This project contributes to the DHA's broader mission of...
- This Project Grant award of $894,330.00 from the U.S. Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is funding research conducted by the University of Miami to investigate "Targeting Axonal Regeneration Pathways as a Therapeutic Approach to ALS." The project aims to transform healthcare for military service members and the broader public by advancing biomedical research into innovative medical solutions for critical health challenges. The award...
- Federal Grant Award Summary The University of Florida's Division of Sponsored Research received a $996,586 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective May 15, 2025, through May 14, 2028. This three-year research initiative investigates alcohol use as a moderating factor in serotonergic neurodegeneration during the early stages of Alzheimer's disease. The award supports hypothesis-driven biomedical...
- Florida State University's Sponsored Research Administration division received a $885,480 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, through August 31, 2028. The award supports a three-year ecological momentary assessment study investigating daily patterns and predictors of cognitive function in middle-aged and older adults with neurofibromatosis type 1 (NF1). This research...
- Federal Grant Award Summary The University of Michigan's Office of Research and Sponsored Projects received a $248,156 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period October 1, 2025 through September 30, 2027. The award supports research focused on identifying molecular biomarkers for invasive glioblastoma cell states and tumor microenvironment modulation. This research initiative will be conducted at...
- The University of Miami has been awarded a $1,700,000.00 Project Grant from the Department of Defense (DoD) through the Military Medical Research and Development (CFDA 12.420) federal grant program. This grant will support advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The research funded under this 2-year grant, with a performance period from September 15, 2024 to September 14, 2026, will explore innovative...
- This Project Grant award, totaling $1,535,000.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Miami. The award will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the research will target the reflux-activated oncogenic mRNA translation program in esophageal adenocarcinoma, with a performance period from...
- Federal Grant Award Summary The University of Michigan received a $838,945 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period of July 1, 2026, through June 30, 2028. The award supports research addressing TDP43-dependent disease mechanisms in amyotrophic lateral sclerosis (ALS) through selective pharmacological cochaperones. This research initiative will be conducted at the University of Michigan's Ann Arbor...